DE69329108T2 - Verfahren zur inaktivierung von viren - Google Patents

Verfahren zur inaktivierung von viren

Info

Publication number
DE69329108T2
DE69329108T2 DE69329108T DE69329108T DE69329108T2 DE 69329108 T2 DE69329108 T2 DE 69329108T2 DE 69329108 T DE69329108 T DE 69329108T DE 69329108 T DE69329108 T DE 69329108T DE 69329108 T2 DE69329108 T2 DE 69329108T2
Authority
DE
Germany
Prior art keywords
inactivating viruses
supercritical
inactivating
directed
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69329108T
Other languages
English (en)
Other versions
DE69329108D1 (de
Inventor
P Castor
D Lander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOENG Inc
Original Assignee
BIOENG Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOENG Inc filed Critical BIOENG Inc
Application granted granted Critical
Publication of DE69329108D1 publication Critical patent/DE69329108D1/de
Publication of DE69329108T2 publication Critical patent/DE69329108T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
DE69329108T 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren Expired - Fee Related DE69329108T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84451392A 1992-03-02 1992-03-02
PCT/US1993/001916 WO1993017724A1 (en) 1992-03-02 1993-03-02 Viral inactivation method

Publications (2)

Publication Number Publication Date
DE69329108D1 DE69329108D1 (de) 2000-08-31
DE69329108T2 true DE69329108T2 (de) 2001-03-22

Family

ID=25292924

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329108T Expired - Fee Related DE69329108T2 (de) 1992-03-02 1993-03-02 Verfahren zur inaktivierung von viren

Country Status (6)

Country Link
US (2) US5877005A (de)
EP (1) EP0629135B1 (de)
JP (1) JP4260877B2 (de)
AT (1) ATE194921T1 (de)
DE (1) DE69329108T2 (de)
WO (1) WO1993017724A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329108T2 (de) * 1992-03-02 2001-03-22 Bioeng Inc Verfahren zur inaktivierung von viren
FR2699408B1 (fr) * 1992-12-21 1995-03-24 Bioland Procédé de traitement de tissus osseux et biomatériaux implantables correspondants.
FR2735372B1 (fr) * 1995-06-13 1997-09-05 Bioland Nouvelles utilisations d'un courant de dioxyde de carbone supercritique a titre d'agent antiviral
US5723012A (en) * 1993-12-09 1998-03-03 Bioland Uses for a current of supercritical carbon dioxide as an antiviral agent
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
US6149864A (en) * 1998-06-25 2000-11-21 Massachusetts Institute Of Technology Supercritical fluid sterilization method
WO2001047566A1 (fr) * 1999-12-27 2001-07-05 Kabushiki Kaisha Sr Kaihatsu Procede et appareil permettant de desinfecter/steriliser des instruments medicaux
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
EP1409108A4 (de) * 2001-06-25 2007-11-14 Lipid Sciences Inc Hohlfaserberührungssysteme zur entfernung von lipiden aus fluiden
WO2003000381A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
EP1412045A4 (de) * 2001-06-25 2007-05-02 Lipid Sciences Inc Ein lösungsmittel zur entfernung von lipiden aus fluiden verwendende systeme und verfahren
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7033813B2 (en) * 2001-09-05 2006-04-25 Trevor P Castor Inactivated vaccines for aids and other infectious diseases
US7291352B2 (en) 2001-10-03 2007-11-06 Herbalscience Llc Methods and compositions for oral delivery of Areca and mate' or theobromine
US7105185B2 (en) 2001-10-03 2006-09-12 Herbalscience, Llc Kavalactone profile
US20050053678A1 (en) * 2001-10-03 2005-03-10 Gow Robert T. Methods and compositions for betel nut chewing gum
US20050069596A1 (en) * 2001-10-03 2005-03-31 Gow Robert T. Compositions and methods comprising kava and anti-anxiety compounds
US7029707B2 (en) * 2001-10-03 2006-04-18 Herbalscience, Llc Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
US7037524B2 (en) * 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
US7001620B2 (en) 2001-10-03 2006-02-21 Herbal Science, Llc Kavalactone product
US7008591B2 (en) * 2001-10-17 2006-03-07 Edwards Lifesciences Corporation Supercritical fluid extraction process for tissue preparation
JP2005538148A (ja) * 2002-08-26 2005-12-15 リピド サイエンスィズ インコーポレイテッド 脱脂タンパク質粒子を使用したアルツハイマー病治療
US20050037025A1 (en) * 2002-10-03 2005-02-17 Gow Robert T. Methods and compositions comprising kava and mate' or theobromine
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
JP2007527387A (ja) * 2003-07-03 2007-09-27 リピッド サイエンシーズ,インコーポレイテッド 脂質含量の低下したhdlの粒子誘導体を製造するための方法及び装置
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
US7294353B2 (en) * 2003-10-24 2007-11-13 Herbalscience, Llc Methods and compositions comprising ilex
US7279184B2 (en) * 2003-10-24 2007-10-09 Herbalscience, Llc Methods and compositions comprising Ilex
US8328876B2 (en) * 2003-12-31 2012-12-11 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
US7387749B2 (en) * 2004-02-20 2008-06-17 Wayne State University Method of delaminating aggregated particles with a coating agent in a substantially supercritical fluid
TWI302944B (en) * 2004-07-12 2008-11-11 Method for removing virus activity from biological materials
CN1318581C (zh) * 2004-07-13 2007-05-30 南玮实业股份有限公司 利用超临界流体去除冠状病毒活性的方法
US20060269928A1 (en) * 2005-05-27 2006-11-30 Aphios Corporation Compositions, methods and apparatus for supercritical fluid virus inactivation
WO2007053850A2 (en) 2005-11-01 2007-05-10 Osteotech, Inc. Bone matrix compositions and methods
KR20080005678A (ko) * 2006-07-10 2008-01-15 삼성전자주식회사 인쇄회로기판 및 이를 갖는 전자장치
CA2690457C (en) * 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
US9554920B2 (en) * 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
WO2008157497A2 (en) * 2007-06-15 2008-12-24 Osteotech, Inc. Method of treating tissue
WO2008157492A2 (en) 2007-06-15 2008-12-24 Osteotech, Inc. Osteoinductive demineralized cancellous bone
US9492278B2 (en) 2007-07-10 2016-11-15 Warsaw Orthopedic, Inc. Delivery system
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
EP2183268B1 (de) 2007-08-17 2012-10-10 CSL Behring GmbH Verfahren zur aufreinigung von alpha-1-antitrypsin und apolipoprotein a-i
WO2009052492A2 (en) 2007-10-19 2009-04-23 Osteotech, Inc. Demineralized bone matrix compositions and methods
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
WO2010093955A1 (en) 2009-02-12 2010-08-19 Osteotech,Inc. Segmented delivery system
WO2010148117A1 (en) 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
SG194880A1 (en) 2011-05-27 2013-12-30 Cormatrix Cardiovascular Inc Sterilized, acellular extracellular matrix compositions and methods ofmaking thereof
US8956566B2 (en) 2012-03-12 2015-02-17 Pure Biosolutions, Llc System and method for virus inactivation
JP6182210B2 (ja) * 2012-06-29 2017-08-16 イー・エム・デイー・ミリポア・コーポレイシヨン タンパク質精製プロセス中のウイルスの不活性化方法
US8791054B2 (en) * 2012-09-27 2014-07-29 Halliburton Energy Services, Inc. Methods of converting an inactive biocide into an active biocide using a chemical reaction
RU2713126C2 (ru) 2014-10-24 2020-02-03 Джензим Корпорейшн Способ предотвращения контаминации системы
EP3088006A1 (de) * 2015-04-28 2016-11-02 Bayer Technology Services GmbH Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor
JP2018082987A (ja) * 2016-11-25 2018-05-31 株式会社日立製作所 ウイルス不活化方法及びウイルス不活化装置
WO2019104237A1 (en) 2017-11-22 2019-05-31 Hdl Therapeutics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
AU2018396009A1 (en) 2017-12-28 2020-07-16 Hdl Therapeutics, Inc. Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma
RU2691983C1 (ru) * 2018-02-27 2019-06-19 Общество с ограниченной ответственностью "Матрифлекс" Способ очистки, модификации и стерилизации производных костной ткани и кожного матрикса с использованием сверхкритического флюида
KR102565569B1 (ko) * 2018-03-30 2023-08-09 아사히 가세이 메디컬 가부시키가이샤 혈액 정화기 및 그 제법
WO2021048221A1 (en) * 2019-09-09 2021-03-18 Valneva Austria Gmbh Inactivation process for viruses
WO2023063933A1 (en) * 2020-10-12 2023-04-20 Castor Trevor P Apparatus and method for inactivating viruses and pathogens in human plasma units
WO2022109430A1 (en) * 2020-11-22 2022-05-27 Castor Trevor P Sustained release inactivated vaccines
WO2023063932A1 (en) * 2021-10-12 2023-04-20 Castor Trevor P Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32695E (en) * 1979-04-12 1988-06-14 Dasi Industries, Inc. Method and apparatus for treating fluent materials
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
WO1991001367A1 (en) * 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
DE69329108T2 (de) * 1992-03-02 2001-03-22 Bioeng Inc Verfahren zur inaktivierung von viren
US5667835A (en) * 1993-10-27 1997-09-16 Nippan Tansan Co., Ltd. Method for inactivating enzymes, microorganisms and spores in a liquid foodstuff
US5520943A (en) * 1993-10-27 1996-05-28 Nippon Tansan Co., Ltd. Method for modifying the quality of liquid foodstuff

Also Published As

Publication number Publication date
WO1993017724A1 (en) 1993-09-16
ATE194921T1 (de) 2000-08-15
JPH07505071A (ja) 1995-06-08
EP0629135A1 (de) 1994-12-21
DE69329108D1 (de) 2000-08-31
JP4260877B2 (ja) 2009-04-30
US5877005A (en) 1999-03-02
EP0629135B1 (de) 2000-07-26
US6465168B1 (en) 2002-10-15

Similar Documents

Publication Publication Date Title
DE69329108D1 (de) Verfahren zur inaktivierung von viren
DE3750437D1 (de) Verfahren, Apparat und System zur Wiedererkennung von Rundfunkausschnitten.
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE3888205T2 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
DE3786840D1 (de) Vorrichtung und verfahren zur oberflaechenbehandlung mit plasma.
DE69435010D1 (de) Verfahren und stoffe für die behandlung von individuen, die infiziert sind mit intrazellulär infektiösen agentien
DE3781854D1 (de) Verfahren und vorrichtung zur genauen untersuchung des aussehens von artikeln.
DE3885358T2 (de) Vorrichtung und verfahren zur behandlung des randes eines brillenglases.
DE69000784D1 (de) Verfahren zur immobilisierung von schlaedlichen metallen und organischen stoffen.
DE3784188T2 (de) Verfahren zur behandlung von industriellen gasen, die schwefelverbindungen enthalten.
DE3781535D1 (de) Verfahren und vorrichtung zur aseptischen behandlung von lebensmitteln.
DE3788749D1 (de) Verfahren und Vorrichtung zur Feststellung von molekularen und ionischen Spezies.
DE3873094T2 (de) Verfahren zur aufbereitung von gas.
DE69021729T2 (de) Verfahren zur gewinnung von natürlich hergestelltem chymosin.
DE68910928D1 (de) Verfahren und Vorrichtung zur zentrifugalen Behandlung von Flüssigkeiten.
DE59002221D1 (de) Verfahren und vorrichtung zur entsorgung von organischen daempfen, insbesondere von loesemitteldaempfen.
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
ATA134593A (de) Verfahren und vorrichtung zur nachbehandlung von gebeizten stahlprodukten, insbesondere von gebeiztem c-stahl-warmband
DE59002951D1 (de) Verfahren und vorrichtung zur vakuumbehandlung von metallen.
DE69011044T2 (de) Verfahren und Vorrichtung zur Behandlung von Abgas.
DE3777022D1 (de) Verfahren und praeparat zur inaktivierung von viren.
DE69111457T2 (de) Katheter und vorrichtung zur behandlung, insbesondere von lungenembolien.
DE3481179D1 (de) Vorrichtung und verfahren zur plasmabehandlung von kunstharz.
DE3770371D1 (de) Vorrichtung und verfahren zur oberflaechenbehandlung von rohren mit fluessigkeiten.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee